Clinical trial
Efficacy and Safety of Aripiprazole 2.5mg Combine Sertraline 50mg in Major Depression
NCT00873795 is registered in ClinicalTrials.gov with Chimei Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Aripiprazole 2.5mg Combine Sertraline 50mg in Major Depression
- Lead sponsor
- Chimei Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- March 31, 2009
- Enrollment
- 41 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.